Last10K.com

Endologix Inc (ELGX) SEC Filing 8-K Material Event for the period ending Wednesday, October 24, 2018

Endologix Inc

HISTORY TOOLS
CIK: 1495240 Ticker: ELGX

View differences made from one to another to evaluate Endologix Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Endologix Inc.

Continue

Assess how Endologix Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Endologix Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Endologix Inc provided additional information to their SEC Filing as exhibits

Exhibit 1.1: Underwriting Agreement
Exhibit 5.1: Opinion Regarding Legality
Exhibit 99.1: Additional Exhibits
Exhibit 99.2: Additional Exhibits
Ticker: ELGX
CIK: 1013606
Form Type: 8-K Corporate News
Accession Number: 0001193125-18-309084
Submitted to the SEC: Fri Oct 26 2018 4:04:09 PM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Wednesday, October 24, 2018
Industry: Surgical And Medical Instruments And Apparatus
Events:
  1. Financial Exhibit
  2. New Agreement
  3. Regulated Disclosure

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/elgx/0001193125-18-309084.htm